|
|
Other New Drugs
Other New Drugs
- Major Setback for Experimental Therapeutic HIV Vaccine (July 10, 2008)
In aidsmap.com
- Suppression of Human Protein Reduces HIV's Ability to Enter T Cells, Replicate, Study Finds (April 30, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Kind of Antiretroviral, KP-1461, Clinical Trial Recruiting; Interview With Stephen Becker, M.D. (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
- Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says (April 20, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Australia: Biotron Anti-HIV Compound, Virion, Shown to Act Against HIV (August 23, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Gilead's Fixed-Dose Combination of Truvada + Efavirenz Not Yet Bioequivalent to Drugs Alone (August 10, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Vulnerability Found in AIDS Virus, German Scientists Say (August 3, 2005)
In vitro tests find that a peptide appears to halt HIV assembly.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Tat Inhibitors, a New Approach: Interview With Olaf Kutsch, Ph.D. (February 28, 2005)
Years ago, a Tat inhibitor worked well in the lab but failed in patients; modern biotechnology, however, may give the drug new life.
In AIDS Treatment News, from AIDS Treatment News
- Behind the December 2004 "AIDS Breakthrough" Headlines (December 31, 2004)
Mid-December press reports were exaggerated, but still important; they focus on DAPYs, a promising new family of HIV meds.
In AIDS Treatment News, from AIDS Treatment News
- Statins May Help Treat HIV (October 2004)
Quick recap of a recent study on Mevacor in the Journal of Experimental Medicine.
To read PDF, click here
In HIV Treatment ALERTS!, from The Center for AIDS
- Treatment of HIV Infection With Prednisolone (July 13, 2004)
In The XV International AIDS Conference, from The Body PRO
- Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases
- Novel Agents Show Promise as Anti-HIV Compounds (December 30, 2003)
Pyridine oxide derivatives may not only prevent HIV replication, they may prevent the virus from reactivating as well.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Capsid Protein Assembly Inhibitors: Potential New Class of Antiviral Drugs (May 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs (March 31, 2003)
From U.S. National Institute of Allergy and Infectious Diseases
- Digging Deeper at the Resistance Workshop (August 14, 2002)
Key clinical findings from July's XI International HIV Drug Resistance Workshop.
From International AIDS Society
- New Cancer Drugs Might Help Treat HIV -- But Research Not Done (April 12, 2002)
In AIDS Treatment News, from AIDS Treatment News
- HE2000: An Immune System Regulator (February 2002)
In Reasons for Hope, from Search for a Cure
- New Immune-Based Treatment Approach: Trial Recruiting in San Francisco (February 23, 2001)
In AIDS Treatment News, from AIDS Treatment News
- HE2000 Begins Clinical Trials: Interview With James Frincke, Ph.D. (June 4, 1999)
From AIDS Treatment News
- New Antiviral Substances Found With HCG (March 19, 1999)
From AIDS Treatment News
- RU-486 (Spring 1999)
In Notes From the Underground, from PWA Health Group
- Immunologic Parameters Modified in HIV Disease by the Drug WF10 (a Phase II Pathogenesis Study) (February 2, 1999)
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
|
|
